Rituxan 500 mg/50 mL solution for intravenous infusion Images
Generic Name: rituximab
This medication has been identified as Rituxan 500 mg/50 mL solution for intravenous infusion. It is supplied by Genentech, Inc.
Rituxan is used in the treatment of Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Chronic Lymphocytic Leukemia; Granulomatosis with Polyangiitis; Non-Hodgkin's Lymphoma and belongs to the drug classes antirheumatics, CD20 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Rituxan 500 mg/50 mL solution for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Rituxan
- Generic Name
- rituximab
- Strength
- 500 mg/50 mL solution for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Antirheumatics, CD20 monoclonal antibodies
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0053
More about Rituxan (rituximab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (38)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.